Background: The goal was to test the effectiveness of a structured pain management programme after invasive electrophysiological interventions in cardiology including ablation of atrial fibrillation (AF) or ventricular tachycardia (VT) and implantation, or explantation, of pacemakers or implantable cardioverter defibrillators. Methods: This was a prospective study with a pre-/post-design where a post-intervention group (116 consecutive patients) was compared to a pre-intervention group (102 consecutive patients) after implementation of a structured pain-management programme using the numeric rating scale (NRS 0-10) and classified as moderate-to-severe if NRS > 3. Measurements were recorded every two hours during the first 24 h post-operatively. The location of the pain and the amount of analgesic used were also recorded. Results: The proportion of patients who experienced moderate-tosevere pain after the procedure decreased after initiation of the painmanagement program: 47% versus 61%; p = 0.048. This difference was driven primarily by reduced pain late (8-24 h) after the procedure; 16% versus 39%; p < 0.001. The risk to develop late (8-24 h) post-procedural pain was reduced approximately three-fold after implementation of the pain-management programme (OR = 0.32, 95% CI 0.16-0.64, p = 0.001). Multivariate analysis indicated chronic pain, early pain (0-6 h), and type of intervention were associated with late postinterventional pain. In contrast, age, diabetes mellitus, BMI, gender and procedure time were not related. Conclusion: The findings illustrate the potential value of a structured pain-management programme. The proportion of patients who experienced moderate-to-severe pain after these electrophysiological procedures decreased significantly. Significance: This is the first exploratory study that evaluates the impact of a multidisciplinary pain-management programme after cardiac electrophysiological interventions. It demonstrates that significant quality improvement is achievable following simple rules together with patient and staff education. The programme reduces the proportion of patients with moderate-to-severe pain after electrophysiological procedures significantly.
Introduction
Invasive cardiac electrophysiological (EP) procedures such as ablation and also surgical interventions for cardiac implantable electronic devices (CIEDs; that is, pacemakers and implantable cardiac defibrillators (ICD)) are all associated with different degrees of pain. This pain can be experienced not only during the procedure, but also in the first days afterwards. We previously reported patients' self-rated pain intensity after AF/VT ablation or cardiac device surgeries (Bode et al., 2015) . These procedures were associated with a high prevalence ( Fig. 1 ) and poor predictability of post-operative pain despite the use of peri-interventional analgesics if the pain management was left to the individual physician's discretion. However, we propose that a structured approach to pain management should yield greater efficacy. Several factors appeared to contribute to the failure of the unstructured approach; unawareness of potential pain after EP-procedures, deficiencies in knowledge about pain assessment and management, and the lack of specific, guideline-driven instruction in our hospital (Laubenthal and Neugebauer, 2009 ). Deficits in pain-management is also seen in other fields. For example, up to 50% of patients experience post-operative pain regardless of hospital type, site of surgery, or country (Pogatzki-Zahn et al., 2015) . Furthermore, even minor operations, including some employing laparoscopic approaches, resulted in unexpectedly high levels of post-operative pain (Gerbershagen et al., 2013) . Untreated pain, regardless of its cause, represents, nevertheless, substantial emotional distress for patients. Such pain also increases the risk of immobilization, prolongs hospital stay, has negative immunomodulating effects (Page et al., 2001) , diminishes patient satisfaction, and decreases the likelihood of seeking health care for future procedures at a particular institution (Trout et al., 2000) . Pain assessment and management programmes have been introduced and evaluated in orthopaedic, visceral, gynaecological, urological, and other surgical specialties (Usichenko et al., 2013; Pogatzki-Zahn et al., 2015) . However, as far as we are aware, there has been no similar investigation after electrophysiological interventions. The Heart Center of Leipzig together with its Cardiology, Electrophysiology, Paediatric cardiology and Cardiac surgery divisions instituted a quality improvement process in pain-management and achieved certification for pain-management by the Society for Qualified Pain Management CERTKOM e.V.in 2013.
This real-life study, conducted in a high-volume centre that specializes in interventional electrophysiology and device therapy, had two goals; (1) to evaluate the effectiveness of a structured pain assessment and management programme on the burden of self-rated pain and (2) to determine the predictors for increased pain perception after intervention.
Methods

Patients
This prospective study with a pre-/post-design was performed in the department of electrophysiology at the Heart Center in Leipzig, Germany in accordance with the Declaration of Helsinki and was approved by the local ethics committee. Informed consent was obtained from each patient. Details of the pre-intervention group have been published elsewhere (Bode et al., 2015) . In the post-intervention group, 116 consecutive patients undergoing the mentioned procedures in the inpatient unit of the electrophysiology department were enrolled within a 5-week period in July and August 2015. One hundred and two consecutive patients from our previous study were used as the pre-intervention control group, where pain management was left to the treating physicians' discretion and no pain management programme existed (Bode et al., 2015) . Participants were asked to quantify post-interventional pain using a paper-based numeric rating scale (NRS 0-10; Chapman et al., 1985) . They recorded values over a 24-h period every two hours after their electrophysiological intervention. Patients also specified the location of their pain (multiple location sites were allowed on the form).
A validated linear Numeric Rating Scale (NRS) was used to quantify patients' discomfort level. The information obtained can be used to guide analgesic therapy and to control therapeutic efficacy (Bolton and Wilkinson, 1998; Hjermstad et al., 2011) . On the NRS scale, the patient reports a pain level ranging between 0 and 10; 0 indicates no pain and 10 indicates the worst pain imaginable. NRS is considered the most sensitive and responsive scale available. In addition, it is easy to apply for both patients and clinicians and provides data for parametric analyses (Ferreira-Valente et al., 2011) . This scale was therefore used as an indirect tool to measure the performance of our intervention programme. The frequency of post-operative, in-hospital oral and parenteral analgesic (both nonopioid and opioid) use was also recorded. One hundred and two consecutive patients from our previous study were used as the pre-intervention control group.
Intervention strategy
According to the results of the pre-intervention group and identified barriers for insufficient performance an interdisciplinary structured pain management policy was established at the inpatient unit of the department of electrophysiology with the following items:
The clinicians are advised to (1) pay a closer attention to the continuation of domestic pain medication; (2) prescribe complete recommended doses of painkillers; (3) inform patients on all given pain medications.
Patients receive structured information in the form of educational material (see document in Appendix S1a,b). In addition, oral explanations were provided by nurses and doctors. These included descriptions of the pain measurements and treatment methods. Also, the staff emphasized that patients should disclose any pain they experienced.
Nurses have been advised to ask patients about their pain intensity after interventions with the help of NRS every two hours on the day of procedure, and evaluate and document pain intensity at least every 12 h apart from this.
Procedure specific, multimodal analgesic protocols, according to the national guidelines adopted to the needs of the EP-unit were developed and introduced: o Analgesics are now offered to the patient at NRS > 3 or if the patient asks for it at a lower pain level. o Due to the potential side effects of analgesics, the fact that pain resolved to low levels within the first 24 h in most of our patients, and the fact that 40% of our patients denied moderate to severe pain within the first 24 h during the preintervention period, oral nonopioid pain-killers for acute post-interventional pain are prescribed on demand and not after a fixed time scheme. o Oral nonopioid analgesics (mostly metamizol if no contraindications) on demand are prescribed in the patient folder by doctors the evening before the intervention according the patient's co-morbidities and laboratory results. On the day of the intervention, nurses are allowed to give this prescribed medication if pain is not caused by any other critical issues. Typical situations are back pain due to bed rest and pain at the device wound or groins due to incision or puncture. o 30-60 min after the administration of pain killers, a re-evaluation of pain has to be done by nurses and if NRS is still >3, doctors have to be informed and again have to exclude acute reasons for pain requiring further diagnostic and therapy. When indicated, patients are treated with opioids, such as subcutaneous Piritramid with continuous monitoring of vital signs.
A pain nurse attends to patients with chronic pain who are unresponsive to therapy.
Development of a multidisciplinary task-force at
the Heart Center Leipzig.
Under the programme, doctors and nurses are educated on acute and chronic pain management, pain evaluation, WHO-guidelines, and medical and physical therapy options on a regular basis. In total, 45 nurses and 20 doctors were trained. Each staff member received a total of two hours' worth of instruction per year. In addition, audits are performed annually (two internal, one external) to assess the adoption of the policy and to discuss emerging problems with staff.
Ablation procedures
The ablation procedures used were described in detail in Bode et al. (2015) . In brief: all AF and VT ablation procedures were performed under deep sedation and local anaesthesia at the puncture sites (with 20 mL mepivacaine 1%). Intravenous propofol and fentanyl were administered initially as a bolus together with midazolam. They were then titrated to achieve deep sedation, defined as the absence of response to voice, but preserved response to painful stimulation (Gross et al., 2002) . Ablation procedures were performed with transvenous, transseptal or retrograde approach according to the region of interest and guided by an electroanatomic mapping system (EnSite NavX, St. Jude Medical Inc., Saint Paul, MN, USA or CARTO 3, Biosense Webster Inc., Diamond Bar, CA, USA). The duration of an ablation procedure was defined as the time from femoral access puncture to the removal of the sheath.
Device procedures
Implantation, replacement and revision procedures were mostly done in conscious patients. However, one revision procedure was done under deep sedation with fentanyl, midazolam, and propofol because two RV-leads had to be extracted with the help of lockingstylets and extraction sheaths. The duration of CIED implant or explant procedure was defined as the time between the first incision and the last skin suture.
All devices were implanted subcutaneously under local anaesthesia (with 40 mL Mepivacaine 1%) and patients received additional fentanyl for analgesia if necessary. Supplementary sedatives (midazolam alone or in combination with propofol or etomidate) were used in case of intraoperative defibrillation testing or when patients requested it. An infraclavicular incision was made parallel to the deltopectoral groove and subclavian puncture or preparation of the cephalic vein was used as access for the leads. Wound closure was performed with subcutaneous and intracutaneous absorbable sutures.
Statistical analysis
All statistical analysis was conducted using SPSS 22.0 (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk:NY: IBM Corp (USA)). Continuous variables are expressed as mean AE standard deviation (SD) or median with range. Categorical variables are reported in terms of numbers and proportions and their 95% confidence intervals (CI). Comparisons between the pre-and post-intervention group as well the different procedure subgroups and temporal occurrence of pain were performed using Student's t-test for continuous and chi-squared test for categorical variables. Uni-and multivariate logistic regression analysis was used to identify variables associated with pain perception. For this purpose intervention programme, early pain (0-6 h) NRS > 3, age, female sex, BMI, diabetes mellitus, type of intervention and chronic pain were included. The selected variables were fit into a final model to get the correct estimates for the odds ratio. A p-value of <0.05 was considered statistically significant Conventionally, NRS levels are used to classify three pain categories; 0-3 = low, 4-5 = moderate, ≥6 = severe. Because pain therapy is recommended for NRS > 3 (Laubenthal and Neugebauer, 2009) , two pain categories of pain were used in our analyses (NRS ≤ 3 and NRS > 3). If there was at least one self-reported NRS > 3, post-operative pain was considered to have occurred.
Results
Study population
A total of 116 consecutive patients of the post-intervention group underwent 70 ablation procedures (60%) and 46 device surgeries (40%) were included. Table 1 shows the patient and procedure characteristics. Ablations were performed for AF in 56 (48%) and VT in 14 (12%) cases. Device surgeries (n = 46, 40%) included 19 new implantations of single chamber (n = 3), dual chamber (n = 13, in two cases together with explantation of an internal loop recorder) and CRT-devices (n = 3), 18 generator replacements due to battery depletion of single chamber (n = 3), dual chamber (n = 6) and CRT-devices (n = 9), nine revisions of devices with upgrading to dual chamber (n = 2) and CRT-devices (n = 7) together with explantation of two abandoned leads in one case and one device and lead explantation of a CRT-device due to device infection. The pre-intervention group is described in detail in (Bode et al., 2015) . The pre-and post-intervention group were comparable in regard to age, gender, the presence of diabetes mellitus and existing chronic pain. There was evidence for longer procedure times in the postintervention group; two patients received their CRT device after a special and time consuming study protocol and more patients were implanted over cephalic vein. There was also weak evidence to suggest that the post-intervention group had a lower BMI and a different procedure profile.
During ablation procedures, patients in the preand post-intervention group received comparable amounts of analgesics and sedatives (Appendix S2). During rhythm device surgery patient patients in both groups received comparable amounts of sedatives per patients; however, the average dose of fentanyl was less (0.065 AE 0.038 mg/pat (preintervention)/0.036 AE 0.020 mg/pat (post-intervention), p = 0.009, Appendix S2).
Data point collection
Each patient had a median of 10 (mean 9) collected data points (min = 5, max = 13, interquartile range 8-10) in the first 24 h following the intervention. 1068 out of 1508 possible data points were collected successfully. The missing data points were due to patients sleeping and/or early discharge in case of unremarkable clinical state.
Patient discomfort
Overall, the amount of patients suffering from moderate to severe pain (NRS > 3) within the first 24 h after the procedure was less in the post-intervention group; 47% [95% CI 38% to 56%] versus 61% [95% CI 51% to 70%], p = 0.048. This difference was driven primarily by reduced pain intensity in the late (8-24 h) period after the procedures. The percentage of patients who experienced moderate or severe pain late (8-24 h) after their procedure was lower after implementation of the pain-management programme; 16% [95% CI 10% to 23%] versus 39% [95% CI 30% to 47%], p < 0.001. No significant difference was found early (0-6 h) after EP-procedures: pre-intervention: 54% [95% CI 44% to 64%] vs post-intervention: 43% [95% CI 34% to 52%], p = 0.11) due to the fact that (1) our hospital policy does not recommend prophylactic analgesics (to avoid overtreatment of unaffected patients); and (2) even one NRS value >3 would be counted as positive (Fig. 1) . A comparison between patients (pre-and post-intervention) with pain levels NRS > 3 and those with NRS ≤ 3 is shown in Table 2 .
A multivariate analysis including the intervention programme, early pain (0-6 h) NRS > 3, age, female sex, BMI, diabetes mellitus, type of intervention, and chronic pain revealed that the risk to develop late (8-24 h) post-procedural pain is reduced about three times after implementation of the pain management programme (OR = 0.32, 95% CI 0.16-0.64, p = 0.001). Early post-procedural pain (0-6 h) NRS > 3 (OR = 7.96, 95% CI 3.67-17.26, p < 0.001), chronic pain (OR = 3.41, 95% CI 1.38-8.46, p = 0.008) and device procedures compared to ablation procedures (OR = 1.43, 95% CI 1.00-2.04, p = 0.049) are also associated with late post-procedural pain. However, within the post-invention group the unadjusted OR to develop late pain when early pain already exists is less than in the pre-intervention group, OR = 4.74 (95% CI 1.58-14.27; post) and OR = 8.57, (95% CI 3.26-22.55; pre), respectively.
A maximum of 29% in the post-intervention group versus 45% in the pre-intervention group suffered from moderate to severe pain at specific time points (0-6 h). After 16 h in the post-intervention group compared to 22 h in pre-intervention group the percentage of patients with an NRS > 3 decreased to <10% (Fig. 2 ). There were similar rates of analgesic administration in both groups. Irrespective of their NRS-values, 48/102 (47%) patients (34 patients once, 9 patients twice, and 5 patients three times) and 51/116 (44%; 43 once, 6 patients twice, and 2 patients three times), respectively, received post-procedural analgesics. However, 12% more patients in the postintervention group received pain killers in case of NRS > 3 than in the pre-intervention group, OR 1.83, CI 0.80-4.2, p = 0.15). Nevertheless, some patients in both groups received no analgesics despite NRS values >3; 34%, 22% (p = 0.15) in the pre-and post-intervention group, respectively. This occurred because some patients in the post-intervention group refused analgesics. In the pre-intervention group, there was a mixture of this behaviour and no reported pain by some or lack of delivery by staff in the pre-intervention group. In both groups, a similar amount of patients received painkillers at NRSvalues ≤3 (18%, pre-intervention group) and (13%, post-intervention group). This often occurred at night and was presumably done to facilitate sleep; such patient requests were not refused.
When pain perception was classified according to the type of intervention and temporal pattern, there were no significant differences in the number of patients within the ablation group and the device group suffering from early and late post-interventional pain with NRS > 3 (47% (ablation, early) vs. 37% (device, early), p = 0.28 and 17% (ablation, late) versus 15%(device, late), p = 0.78, respectively). The proportion of patients with pain in the ablation and device group decreased significantly between the early and late post-interventional time periods (ablation: p = 0.034; device: p = 0.04).
The identified locations of pain were similar in both groups. However, pain at the device implantation site was cited less in the post-intervention-versus the pre-intervention-group; 22% versus 39%, p = 0.004. Patients in the post-intervention group complained of back pain irrespective of their NRS level (NRS 1-10 captured) in 43%, pain in the groin region after puncture in 12%, pericarditic pain in 7%, at other sites in 8% (multiple locations were possible; Fig. 3) .
The rates of reported pre-existing chronic pain were similar between the pre-and post-intervention group, 15.7% and 16.4%, respectively, but with a lower average NRS value of 0.82 compared to the pre-intervention group (NRS pre = 1.81). However, overall chronic pain levels were low; the range varied between NRS 0-4 (pre) and 0-3 (post). 
Discussion
The primary aim of the study was to obtain information on the type, severity and time-course of postoperative pain perception associated with typical interventional electrophysiological procedures after implementation of a structured pain-management programme.
Our study revealed an overall reduction in the percentage of patients with moderate-to-severe pain levels after EP-procedures once a structured pain management programme had been implemented. Our hospital policy advises analgesic use when NRS > 3 and hence the finding of no difference in the proportion of patients with moderate-to-severe pain between groups in the early period (0-6 h) was expected. Later (8-24 h), there was an improvement. Only 19 out of 116 (16%) patients reported relevant discomfort (NRS > 3) versus 40% in the pre-intervention group. In the pre-intervention group, we noticed differences in pain perception for the early and late post-procedural time period between the ablation and device group without significant amelioration late (8-24 h) after device-procedures. However, in the post-intervention group, both, ablation and device procedures showed similar results with significant improvements in both arms. Our results are consistent with other studies which examined the status of post-operative pain intensity and compared the results before and after establishing an algorithm for treating post-operative pain. These studies were mostly performed in conjunction with major surgery. Usichenko et al. (2013) examined pain intensity after orthopaedic, gynaecologic, visceral and trauma surgery and described 25-30% less pain after implementation of a pain-management system. Furthermore, studies by Diby et al. (2008) (cardiac surgery) and Klammer et al. (2013) (thorax and visceral surgery), claimed reduced pain intensity and an increase in the proportion of patients without relevant pain (NRS ≤ 3) or who were pain-free after initiation of pain-management programmes. In a multicentre study, Pogatzki-Zahn et al. (2015) collected data from major as well as minor surgery. Although, nearly all subtypes recorded a lower point of pain intensity, significantly increased results were revealed especially in minor surgical procedures. Pain-management in minor surgeries is poorly understood and only a few studies have addressed this issue. Our study aimed to close this practice gap and provide an algorithm for treating post-operative pain in the predominantly minor surgeries associated with electrophysiological interventions. Moreover, our results, which are in agreement with the above-referenced studies, underline the importance and efficacy of a post-operative painmanagement programme. It was explicitly intended to evaluate an intervention strategy which is applicable to a broad range of patients on the unit as this would reflect the daily practice.
Multivariate analysis revealed the establishment of a pain management reduced post-operative pain significantly, which underlines the importance of a well-structured pain management. Moreover, chronic pain and early post-procedural pain (0-6 h) are associated with increased risk for late post-procedural pain. This should be seen as an important argument to continue home medication regimes for chronic pain patients and to treat pain as soon as it arises. Furthermore, these pain-predictors can help to focus attention on a special group of patients who require more frequent pain assessment or even identify patients for who require prophylactic or more advanced analgesic use. Patients undergoing device surgery also tend to suffer more frequent post-interventional pain, because they have to cover their wound with a sandbag for several hours to minimize haematoma risk. Bode et al., 2015 identified that female gender was associated with early (0-6 h) post-operative pain. Our analysis was not able to confirm this result. A literature search indicates conflicting results about gender and its association with post-operative pain (Fillingim et al., 2009 ). Consequently, the lack of additional pain-predictors further highlights the importance of a frequent and well-designed pain evaluation protocol. All patients suffering from any pain with NRS values from 1 to 10 were asked to indicate the location of the pain (more than one site could be specified). The majority of the patients complained about back pain, hence patients are obliged to lay on their back for 6 h after removal of four to five femoral sheaths and 12 h after cardiac device surgery. Backpain and pain at the vascular access site are also typical complaints after coronary angiography (Fowlow et al., 1995; Chair et al., 2003) . Some patients also experienced pericarditic pain. All pain locations had similar frequencies in the pre-and the post-intervention groups except for the device implantation side; this had a lower frequency in the post-intervention group. The reason for the difference can be seen in the percentage of device patients, which represented 52% in the pre-intervention group and just 40% in the post-intervention group.
Patients' self-rated pain levels reached NRS > 3 at different times, and therefore the absolute number of patients with pain varied over time. However, the proportion never exceeded 30% in the post-intervention group versus 43% in the pre-intervention group at any given time. Because we evaluated patient pain intensity every two hours post-EP-procedure, in contrast to many other studies who ask patients once after surgery (Gerbershagen et al., 2013; Usichenko et al., 2013; Pogatzki-Zahn et al., 2015) , we were able to demonstrate that in the postintervention group the time period were <10% of the operated patients suffered from moderate to severe pain was shorter, 16 h versus 22 h. Overall, early pain detection followed by immediate administration of appropriate analgesics appear to be crucial steps in reducing pain intensity and duration. This, in fact, favours patient recovery and lightens the work-load for doctors and nurses. But, because the percentage of patients treated with analgesics was the same in both groups (irrespective of whether the right people were treated with the right dose), it seems that additional factors might influence pain perception. An environment where patients feel well-cared for and educated about pain management combined with staff that are aware of potential pain after interventional electrophysiology procedures, who facilitates patients signalling and asks them regularly about pain perception and offers therapyoptions seems to reduce pain perception without the need of medication as well.
Limitations
The study was conducted in a single centre. However, we believe that the study provides an accurate reflection of a typical real life patient cohort at our in-patient electrophysiological unit. Our patients were not allocated at random, therefore bias related to undetected, confounding factors cannot be excluded. The study was limited to the first 24 h after the intervention and we did not assess pain during the intervention, while patients were sleeping, or after hospital discharge. The pain algorithm was tested only on patients undergoing cardiac electrophysiological treatments. Additionally, the procedures were not explicitly standardized, but were specific to the individual situation. This is the first study, as far as we are aware, focusing on quality improvement in the field of pain perception after EP-procedures. In order to generalize our results to different patients, or other cardiac procedures, further investigations controlling for possible secular trends or further determinants of pain perception are required. Nevertheless, our interdisciplinary painmanagement approach should be readily applicable to all kind of patients.
Conclusion
This is the first exploratory study to evaluate the impact of a pain-management programme with administration of analgesics-on-demand versus prophylactic administration after standard interventional electrophysiological procedures. Overall, implementation of our pain assessment and management programme improved patient-centred care. Following simple rules together with patient and staff education on pain and therapeutic options, early pain detection and therapy mitigates patient discomfort especially between 8 and 24 h after the procedure. Predictors such as early post-procedural pain (0-6 h) NRS > 3, chronic pain and device procedures compared to ablation procedures may warrant further attention to identify patients for prophylactic or more advanced analgesics use.
